NGS Solid Tumor Profiling

NGS Solid Tumor Profiling is a targeted next-generation sequencing test that assesses DNA and RNA in solid tumors. Through identification of specific DNA/RNA mutations, NGS is able to provide important clinical information such as available therapies and clinical trials that can be used to create a customized treatment plan for patients.
 

Download Infographic